These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 1532443

  • 1. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 2. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK, Ross GM, Bajwa SB, Mishra RK.
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [Abstract] [Full Text] [Related]

  • 3. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE, Gessner GW, Crooke ST, Heys JR, Weinstock J.
    Life Sci; 1986 Jun 09; 38(23):2087-96. PubMed ID: 2872567
    [Abstract] [Full Text] [Related]

  • 4. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB, Lawlor M, Dunne A, O'Boyle KM.
    J Neurochem; 1995 Sep 09; 65(3):1124-30. PubMed ID: 7643090
    [Abstract] [Full Text] [Related]

  • 5. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 09; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 6. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB, O'Boyle KM.
    Eur J Pharmacol; 1994 Jun 15; 268(1):79-88. PubMed ID: 7925614
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB, Otsuka NY, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P.
    J Biol Chem; 1986 Jun 25; 261(18):8397-406. PubMed ID: 3522568
    [Abstract] [Full Text] [Related]

  • 8. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 9. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr 02; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 10. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
    Murray AM, Waddington JL.
    Pharmacol Biochem Behav; 1990 Jan 02; 35(1):105-10. PubMed ID: 1969161
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH, Gnegy ME.
    Mol Pharmacol; 1989 Jan 02; 35(1):139-47. PubMed ID: 2563306
    [Abstract] [Full Text] [Related]

  • 14. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 15. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Oct 30; 106(1):219-20. PubMed ID: 6241567
    [No Abstract] [Full Text] [Related]

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 30; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 17. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL.
    Eur J Pharmacol; 2004 Feb 23; 486(3):273-80. PubMed ID: 14985049
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519
    [Abstract] [Full Text] [Related]

  • 19. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec 15; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 20. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
    Gredal O, Nielsen M.
    J Neurochem; 1987 Feb 15; 48(2):370-5. PubMed ID: 3491877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.